Q93.89
Other deletions from the autosomes
Clinical Classification Guidelines
Inclusion Terms
- Deletions identified by fluorescence in situ hybridization (FISH)
- Deletions identified by in situ hybridization (ISH)
- Deletions seen only at prometaphase
Medical Intelligence & Overview
ICD-10 Code Q93.89 refers to a category of genetic conditions involving deletions of parts of autosomes—chromosomes that are not sex chromosomes. These deletions can lead to various health issues, depending on the specific genes affected. This code is used when deletions are identified through advanced laboratory techniques such as fluorescence in situ hybridization (FISH) or in situ hybridization (ISH), especially when these deletions are only observable at certain stages of cell division like prometaphase. Understanding this condition helps in diagnosing and managing various genetic disorders caused by chromosomal deletions.
Causes & Symptoms
Clinical Causes: Genetic mutations resulting in deletions of parts of autosomes Errors during cell division leading to missing chromosome segments Inherited genetic alterations or mutations De novo mutations occurring for the first time in the individual
Key Symptoms: Delayed growth and development Intellectual disability or learning difficulties Distinct facial features or physical abnormalities Problems with speech or motor skills Organ or heart defects, depending on the specific genes involved Sensory deficits, such as hearing or vision problems In some cases, no noticeable physical symptoms
Diagnostic & Treatment
Diagnosis Path: Diagnosis of these chromosomal deletions typically involves advanced genetic testing methods. Techniques such as FISH and ISH are used to detect specific DNA sequences and identify deletions at the chromosome level. Sometimes, these deletions are only visible during particular stages of cell division, like prometaphase, requiring specialized laboratory analysis. Karyotyping, microarray analysis, and next-generation sequencing may also aid in confirming the extent and location of genetic deletions. Clinical geneticists interpret these tests in conjunction with physical examinations and medical history to establish a precise diagnosis.
Treatment Protocols: Treatment strategies focus on managing the symptoms and supporting development. Approaches may include specialized educational programs, speech and occupational therapy, medical interventions for associated health issues, and surgical procedures when necessary. Since deletions can affect multiple body systems, a multidisciplinary team ensures comprehensive care. Early intervention is crucial to maximize developmental potential and improve quality of life, although there is no cure for the underlying genetic condition itself.
Clinical Advice & FAQs
Billing Guidance
Is Q93.89 a billable ICD-10 code?
Yes, Q93.89 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q93.89?
Clinical documentation must specify the nature of Other deletions from the autosomes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference